Argent BioPharma Limited (LON:MXC – Get Free Report) shares traded up 4.8% on Thursday . The stock traded as high as GBX 22 ($0.28) and last traded at GBX 22 ($0.28). 264 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 26,353 shares. The stock had previously closed at GBX 21 ($0.27).
Argent BioPharma Stock Performance
The company’s 50 day moving average price is GBX 21.44 and its two-hundred day moving average price is GBX 21.14. The firm has a market cap of £9.65 million, a PE ratio of -13.25 and a beta of 1.03.
About Argent BioPharma
MGC Pharmaceuticals Limited provides phytomedicines worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia.
Featured Stories
- Five stocks we like better than Argent BioPharma
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Why Call Options Volume for These 2 Stocks Spiked Together
- Why Invest in High-Yield Dividend Stocks?
- MarketBeat Week in Review – 7/22 – 7/26
- Find and Profitably Trade Stocks at 52-Week Lows
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Receive News & Ratings for Argent BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Argent BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
